Richard Fox is an accomplished industry veteran with over two decades of experience in data science, computational biology, protein, metabolic, and genome engineering. He has deep knowledge and expertise in directed evolution, biostatistics, computational biology, and machine learning. Dr. Fox is widely recognized for his contributions to the development of AI driven enzyme engineering and data science tools and strategies for the rapid forward engineering of biological systems.
Currently serving as Chief Scientist at Inscripta, Dr. Fox is leading the development of a revolutionary, full-stack, next-generation bio foundry. The GenoScaler® platform is based on novel, massively parallel genome editing workflows, automated HTP phenotyping & genotyping technologies, and a fully integrated software, analysis, and an AI based prediction system that radically reduces the time, cost, and risk associated with the development of sustainable, high value biomanufacturing processes.
Prior to his current role, Dr. Fox held key leadership positions at Intrexon, DuPont Pioneer, and Codexis. He earned a Ph.D. in nuclear engineering and worked for various Fortune 500 companies and the U.S. Navy before transitioning to the fields of bioengineering, data science, and machine intelligence.